Hodgkin lymphoma is still in many aspects enigmatic. In this issue of Blood, Steidl and colleagues present exciting novel insights into pathogenesis and clinical behavior of classical Hodgkin lymphoma by performing array comparative genomic hybridization studies to detect genomic gains and losses in the HRS tumor cells of this malignancy.
展开▼
